BioTissue Email Format
Biotechnology ResearchFlorida, United States201-500 Employees
BioTissue is a mid-sized biotechnology firm based in Miami, Florida, founded in 1997, that focuses on regenerative therapies derived from human amniotic and umbilical cord tissues. It advances the clinical use of placental materials and has treated more than 680,000 patients, with its scientific and clinical work documented across more than 380 peer-reviewed publications. The company serves healthcare professionals seeking regenerative healing options, including applications for ocular surface disease and non-healing corneal defects. In January 2026, BioTissue disclosed a transaction in which assets tied to its surgical and wound care business were sold to BioStem Technologies.